AML · Regulatory · Q2 2026
The EU Anti-Money Laundering Authority does not begin direct supervision until 2028. But 2026 is when the preparation should happen. Firms that leave this for later will find the gap harder and more expensive to close than those who start now.
For the first time in EU history, anti-money laundering law will be a directly applicable Regulation, not a Directive requiring national transposition. That distinction matters. It means there is no longer a national version of the rules. There is one version, binding equally across all member states, interpreted by a single authority, and enforced through a supervisory college that includes Cyprus's own regulators.
The European Anti-Money Laundering Authority (AMLA) was established by Regulation (EU) 2024/1620 and is headquartered in Frankfurt. It is not a replacement for CySEC, ICPAC, or the Central Bank of Cyprus. It is a new layer sitting above national supervisors, setting the standards they must enforce, and directly supervising the highest-risk entities itself.
Under the previous Directive-based system, national regulators had discretion in how they transposed and applied EU rules. Under the new setup, the rules are a directly applicable Regulation. There is no national version, no margin for softer implementation, and no room to argue that local practice differs from EU expectation.
AMLA does not replace your current regulator. It raises the floor that your current regulator must now enforce. In practice, Cyprus-regulated entities will be assessed against a standard that is considerably higher than what inspection has typically required.
For most Cyprus obliged entities (accountants, lawyers, corporate service providers, regulated investment firms, payment institutions), AMLA will exercise indirect supervision through CySEC, ICPAC, and the Central Bank. Direct supervision by AMLA itself will initially apply to approximately 40 high-risk cross-border financial institutions across the EU.
The transition to the new framework is phased. The relevant milestones for Cyprus-regulated entities are as follows:
The new EU AML Regulation is considerably more prescriptive than Cyprus's current Prevention of Money Laundering Law. For Cyprus-regulated entities, the changes that matter most are:
| Compliance Area | Current Position (Cyprus Law) | AMLA Regulation Requirement | Gap Risk |
|---|---|---|---|
| Customer risk rating | Risk-based approach, national guidance | Binding RTS methodology — must align precisely | Elevated |
| MLCO role and governance | MLCO appointment required, duties general | Explicit board-level governance framework, defined escalation, documented oversight | High |
| Enhanced due diligence | Cyprus-transposed triggers (4AMLD/5AMLD) | Extended, standardised EU trigger list — some national EDD frameworks are narrower | Elevated |
| CDD documentation standard | Risk-proportionate, regulator guidance | Broadly consistent — verify against RTS | Low |
| Internal audit of AML framework | Good practice, not always formalised | Mandatory, dedicated AML/CFT internal audit function | High |
| CASPs / crypto entities | CASP registration under CySEC | Full obliged entity status, financial institution-equivalent obligations | Critical |
| SAR / STR filing | MOKAS reporting obligations | Consistent with current requirements | Low |
| Beneficial ownership | UBO registry, 60-day update obligation | Consistent — UBO verification standard clarified | Low |
| Structured data / reporting format | No structured data requirement | Structured data requirements for specific disclosures — may require system changes | Elevated |
From the work we do with regulated firms across Cyprus, most fall into one of four positions relative to where the Regulation will require them to be:
Policies exist and pass current inspection. But they reference national law rather than the EU Regulation, the risk assessment has not been touched since implementation, and nobody has specifically reviewed the AML programme through an internal audit lens. The gap is real but closeable.
CDD is applied consistently and files are in good order. But at board level, things are informal. The MLCO reports to management rather than the board, compliance is not on the board agenda, and there is no written escalation procedure. The Regulation's governance requirements will expose this.
The compliance programme is current, governance is structured, and internal audit reviews AML as a specific item. The main job now is tracking the binding RTS as they are finalised and confirming alignment. Not a rebuild, but not something to set aside either.
For CASPs especially, and for firms that have grown quickly without keeping their compliance structure up to speed, the gap is serious. The Regulation's requirements are not optional improvements. They are conditions for remaining authorised.
In practice, we approach AMLA readiness work in four stages. Each has a different lead time and they do not all run in parallel. The governance work tends to take the longest because it requires board-level engagement and real structural changes, not just documentation updates.
The firms in the best position when July 2027 arrives will be those that finished their gap analysis in 2026 and treated the remediation work as a proper project: one person accountable, a budget, a completion date. Not something done in the margins of everything else.
The Regulation applies to all obliged entities. For Cyprus, the entity types facing the most significant changes relative to where they are now are:
This regulation does not reward firms that wait. The gap between where most Cyprus firms are today and where the Regulation requires them to be is still closeable without major disruption. In twelve months it will be smaller. In twenty-four, it will need closing regardless of what that costs or how inconvenient the timing is.
Start the Conversation
Contact us for a confidential consultation to assess your position against the AMLA framework and design a readiness programme suited to your entity type and timeline.
Book a Consultation